Lankenau Medical Center, part of Main Line Health, is a 370-bed acute care, teaching hospital in Wynnewood, Lower Merion Township, Pennsylvania.

There are 370 beds in Lankenau Medical Center.

During the past decade, Lankenau Medical Center conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 145 clinical trials were completed, i.e. on average, 105.1% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 65 clinical trials were completed. i.e. 120.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lankenau Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "Radiation Therapy Oncology Group" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored and "Eastern Cooperative Oncology Group" with 20 trials sponsored. Other sponsors include 144 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lankenau Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 153 trials as a collaborator, "NRG Oncology" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Lankenau Medical Center" are "Breast Cancer" (23 trials), "Lung Cancer" (19 trials), "Colorectal Cancer" (11 trials), "Prostate Cancer" (11 trials) and "Coronary Artery Disease" (9 trials). Many other conditions were trialed in "Lankenau Medical Center" in a lesser frequency.

Most popular intervention types in "Lankenau Medical Center" are "Drug" (217 trials), "Other" (127 trials), "Biological" (88 trials), "Radiation" (73 trials) and "Procedure" (65 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (45 trials), "Paclitaxel" (35 trials), "Questionnaire Administration" (29 trials) and "Carboplatin" (24 trials). Other intervention names were less common.

The vast majority of trials in "Lankenau Medical Center" are 251 trials for "All" genders, 69 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 145 active trials in "Lankenau Medical Center". 2 are not yet recruiting, 49 are recruiting, 93 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 150 completed trials in Lankenau Medical Center, 4 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Lankenau Medical Center, 8 "Phase 1" clinical trials were conducted, 113 "Phase 2" clinical trials and 145 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 49 trials that are defined as “Not Applicable".